Screener
CONMED CNMD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $19.8M+592% | $23.07M+7.7% | $13.83M+129% | $16.74M-50.4% | $2.86M-94.2% | ||
| $3.98M-9.0% | $4.08M-8.7% | $4.17M-1.4% | $4.07M-3.2% | $4.38M+4.3% | ||
| $5.91M+28.9% | $5.23M+6.7% | $5.5M-60.3% | $4.97M-20.1% | $4.59M-25.1% | ||
| $49.41M-8.0% | $37.1M+27.3% | $13.47M-67.6% | $46.34M+6.9% | $53.69M+4.8% | ||
| $2.68M-48.3% | $2.93M-48.8% | $2.89M-23.5% | $5.11M+26.5% | $5.19M+51.7% | ||
| —— | $11.57M+302% | $4.11M+240% | -$7.11M-76.0% | -$5.19M-51.7% | ||
| $0-100% | $0-100% | $0-100% | $6.19M+0.2% | $6.19M+0.4% | ||
| $6.2M— | $6.2M— | $37.02M— | —— | —— | ||
| $168M+0.6% | $415M+137% | $180M+8.4% | $187M+24.7% | $167M+16.8% | ||
| $5.63M-77.5% | $0-100% | $0-100% | $20M+104% | $25M-85.2% | ||
| -$36.96M+15.1% | -$46.23M-74.3% | -$22.55M+20.6% | -$37.37M+26.8% | -$43.53M-12.1% | ||
| $10.64M+113% | —— | -$5.79M-152% | $1.89M— | $4.99M-48.0% | ||
| $46.73M-3.7% | $34.16M+46.0% | $10.58M-72.0% | $41.22M+4.9% | $48.5M+1.5% |
FAQ
- How much cash does CONMED generate?
- CONMED (CNMD) generated $146.3M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $13.6M of capital expenditures, CONMED's free cash flow was $132.7M over the trailing twelve months, down 10.9% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
